Comments
Loading...

Ovid Therapeutics

OVIDNASDAQ
Logo brought to you by Benzinga Data
$1.13
-0.02-1.74%
At close: -
$1.13
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$8.00
Lowest Price Target1
$1.20
Consensus Price Target1
$4.74

Ovid Therapeutics (NASDAQ:OVID) Stock, Analyst Ratings, Price Targets, Forecasts

Ovid Therapeutics Inc has a consensus price target of $4.74 based on the ratings of 7 analysts. The high is $8 issued by Wedbush on April 5, 2024. The low is $1.2 issued by Citigroup on June 18, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on September 30, 2024, August 19, 2024, and July 26, 2024, respectively. With an average price target of $3 between HC Wainwright & Co., there's an implied 165.49% upside for Ovid Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
1
Jun
0
0
0
0
Jul
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
BTIG
B. Riley Securities
Citigroup
Wedbush

1calculated from analyst ratings

Analyst Ratings for Ovid Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Ovid Therapeutics (OVID) stock?

A

The latest price target for Ovid Therapeutics (NASDAQ:OVID) was reported by HC Wainwright & Co. on September 30, 2024. The analyst firm set a price target for $3.00 expecting OVID to rise to within 12 months (a possible 165.49% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Ovid Therapeutics (OVID)?

A

The latest analyst rating for Ovid Therapeutics (NASDAQ:OVID) was provided by HC Wainwright & Co., and Ovid Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Ovid Therapeutics (OVID)?

A

There is no last upgrade for Ovid Therapeutics

Q

When was the last downgrade for Ovid Therapeutics (OVID)?

A

There is no last downgrade for Ovid Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Ovid Therapeutics (OVID)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ovid Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ovid Therapeutics was filed on September 30, 2024 so you should expect the next rating to be made available sometime around September 30, 2025.

Q

Is the Analyst Rating Ovid Therapeutics (OVID) correct?

A

While ratings are subjective and will change, the latest Ovid Therapeutics (OVID) rating was a reiterated with a price target of $3.00 to $3.00. The current price Ovid Therapeutics (OVID) is trading at is $1.13, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch